Accelerate Diagnostics, Inc Business Finance Contracts & Agreements
51 Contracts & Agreements
- Assignment Agreements (1 contract)
- Exchange Agreements (4)
- Forbearance Agreements (1)
- Indenture Agreements (2)
- Note Agreements (6)
- Purchase Agreements (8)
- Registration Rights Agreements (1)
- Security Agreements (2)
- Stock Agreements (10)
- Subscription Agreements (1)
- Trust Agreements (1)
- Underwriting Agreements (2)
- Waiver Agreements (2)
- Warrant Agreements (10)
- Form of Subscription Agreement (Filed With SEC on January 25, 2024)
- Warrant Agency Agreement, dated January 23, 2024, between Accelerate Diagnostics, Inc. and Broadridge Corporate Issuer Solutions (Filed With SEC on January 25, 2024)
- Form of Warrant Agency Agreement (Filed With SEC on January 18, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on January 18, 2024)
- Form of Warrant (Filed With SEC on January 18, 2024)
- Form of Warrant Agency Agreement (Filed With SEC on January 16, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on January 16, 2024)
- Form of Warrant (Filed With SEC on January 16, 2024)
- Form of Underwriting Agreement (Filed With SEC on January 16, 2024)
- First Amendment to Note Exchange Agreement, dated December 11, 2023, between the Company and certain investors named therein (Filed With SEC on December 13, 2023)
- First Amendment to Note Purchase Agreement, dated December 11, 2023, between the Company and certain investors named therein (Filed With SEC on December 13, 2023)
- First Amendment to Securities Purchase Agreement, dated December 12, 2023, between the Company and the Jack W. Schuler Living Trust (Filed With SEC on December 13, 2023)
- New Securities Purchase Agreement, dated June 9, 2023, between the Company and the Jack W. Schuler Living Trust (Filed With SEC on June 13, 2023)
- Amendment No. 1 to Securities Purchase Agreement, dated June 9, 2023, between the Company and the Jack W. Schuler Living Trust (Filed With SEC on June 13, 2023)
- Consent and Amendment No. 1 to Secured Promissory Note, dated June 9, 2023, between the Company and the Jack W. Schuler Living Trust (Filed With SEC on June 13, 2023)
- Form of Security Agreement, dated June 9, 2023, between the Company, as issuer, subsidiaries of the Company, as guarantors, and U.S. Bank Trust Company, National Association, as... (Filed With SEC on June 13, 2023)
- Note Purchase Agreement, dated June 9, 2023, between the Company and certain investors named therein (Filed With SEC on June 13, 2023)
- Note Exchange Agreement, date June 9, 2023, between the Company and certain investors named therein (Filed With SEC on June 13, 2023)
- Indenture, dated June 9, 2023, between the Company and U.S. Bank Trust Company, National Association (Filed With SEC on June 13, 2023)
- Description of our Capital Stock Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 31, 2023)
- Forbearance Agreement, dated as of March 9, 2023, by and among the Company, the Ad Hoc Noteholder Group and the Trustee (Filed With SEC on March 14, 2023)
- Underwriting Agreement, dated August 18, 2022, by and between Accelerate Diagnostics, Inc. and William Blair & Company, L.L.C., as representative of the several underwriters named... (Filed With SEC on August 23, 2022)
- Security Agreement, dated as of August 15, 2022, by and between the Company and the Jack W. Schuler Living Trust (Filed With SEC on August 15, 2022)
- Warrant, dated as of August 15, 2022, issued to the Jack W. Schuler Living Trust (Filed With SEC on August 15, 2022)
- Secured Promissory Note, dated as of August 15, 2022, by the Company in favor of the Jack W. Schuler Living Trust (Filed With SEC on August 15, 2022)
- Exchange Agreement, dated as of August 15, 2022, by and between the Company and the Jack W. Schuler Living Trust (Filed With SEC on August 15, 2022)
- Securities Purchase Agreement, dated March 24, 2022, by and between Accelerate Diagnostics, Inc. and the Jack W. Schuler Living Trust (Filed With SEC on March 25, 2022)
- Description of our Capital Stock Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 14, 2022)
- Form of Exchange Agreement (Filed With SEC on September 23, 2021)
- Securities Purchase Agreement, dated September 22, 2021, by and among Accelerate Diagnostics, Inc., the Tanya Eva Schuler Trust, the Therese Heidi Schuler Trust and Schuler... (Filed With SEC on September 23, 2021)
- Rescission Agreement, dated September 17, 2021, by and among Accelerate Diagnostics, Inc., the Tanya Eva Schuler Trust, the Therese Heidi Schuler Trust, Schuler Grandchildren LLC... (Filed With SEC on September 23, 2021)
- Registration Rights Agreement, dated December 24, 2020, by and among Accelerate Diagnostics, Inc. and the purchasers party thereto (Filed With SEC on December 28, 2020)
- Securities Purchase Agreement, dated December 24, 2020, by and among Accelerate Diagnostics, Inc. and the purchasers party thereto (Filed With SEC on December 28, 2020)
- Addendum A to Promissory Note, dated April 14, 2020, by and between Registrant and Zions (Filed With SEC on November 6, 2020)
- Promissory Note, dated April 14, 2020, by and between Accelerate Diagnostics, Inc. and Zions Bancorporation, N.A. dba National Bank of Arizona (Filed With SEC on April 20, 2020)
- Form of 2020 Salary Waiver Agreement (Filed With SEC on April 8, 2020)
- 2020 Salary Waiver and Nonqualified Stock Option Grant Plan (Filed With SEC on April 8, 2020)
- Description of our Capital Stock Registered Pursuant to Section 12 of the Securties Exchange Act of 1934 (Filed With SEC on February 28, 2020)
- Securities Purchase Agreement, dated August 20, 2019, between Accelerate Diagnostics, Inc. and John J. Phillips Investment Irrevocable Trust, dated July 31, 2019 (Filed With SEC on August 21, 2019)
- Nonqualified Stock Option Agreement between Accelerate Diagnostics, Inc. and John J. Phillips, dated August 6, 2019 (Filed With SEC on August 8, 2019)
